Park Ha Biological (BYAH) director Sheng Qixiong files initial Form 3

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. director Sheng Qixiong has filed an initial statement of beneficial ownership as a reporting person. This Form 3 lists him as a director but shows no reported transactions, acquisitions, or derivative positions at the time of the filing.

Key Terms

Form 3, beneficial ownership, reporting person, director

4 terms

Form 3 regulatory

"has filed an initial statement of beneficial ownership as a reporting person"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial statement of beneficial ownership as a reporting person"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"identifies Sheng Qixiong as a director and reporting person"

director financial

"identifies Sheng Qixiong as a director and reporting person"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sheng Qixiong

(Last) (First) (Middle)

NO. 290, JINCHENG ROAD, XINWU DISTRICT

(Street)

WUXI 214000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2024

3. Issuer Name and Ticker or Trading Symbol
Park Ha Biological Technology Co., Ltd. [ BYAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Sheng Qixiong	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the BYAH Form 3 filed by Sheng Qixiong show?

The BYAH Form 3 identifies Sheng Qixiong as a director and reporting person but lists no share transactions or derivative positions. It serves as his initial beneficial ownership statement for Park Ha Biological Technology Co., Ltd. at the time of filing.

Did Sheng Qixiong buy or sell BYAH shares in this Form 3?

No, this Form 3 does not report any purchases, sales, or other share transactions by Sheng Qixiong. It only establishes his status as a director and reporting person for Park Ha Biological Technology Co., Ltd. with no trades disclosed in this filing.

Does the BYAH Form 3 disclose any derivative securities for Sheng Qixiong?

No, the filing shows no derivative securities such as options or warrants for Sheng Qixiong. The derivative section is empty, indicating no reported derivative positions tied to his role at Park Ha Biological Technology Co., Ltd. in this initial statement.

What is the purpose of this BYAH Form 3 filing?

This Form 3 serves as Sheng Qixiong’s initial beneficial ownership report as a director of Park Ha Biological Technology Co., Ltd. It provides regulatory disclosure of his status, even though it does not list any share transactions or derivative holdings at this time.

Does the BYAH Form 3 indicate if Sheng Qixiong is a major shareholder?

The Form 3 marks Sheng Qixiong as a director but not as a ten percent owner. It therefore identifies him as an insider due to his board role, rather than based on a large shareholding position, with no specific holdings reported in this filing.